LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 135

Search options

  1. Article: Réplication du VHC dans les PBMC lors d’une infection occulte : impact sur la transmission de l’infection.

    Chevaliez, S

    Virologie (Montrouge, France)

    2021  Volume 9, Issue 4, Page(s) 331

    Title translation Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.
    Language French
    Publishing date 2021-10-22
    Publishing country France
    Document type Journal Article
    ZDB-ID 2118387-9
    ISSN 1950-6961 ; 1267-8694
    ISSN (online) 1950-6961
    ISSN 1267-8694
    DOI 10.1684/vir.2011.2125
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Comment la ribavirine (RBV) améliore-t-elle la réponse virologique à l’interféron a (au cours de l’infection chronique par le virus de l’hépatite C ?

    Chevaliez, S

    Virologie (Montrouge, France)

    2021  Volume 9, Issue 5, Page(s) 414

    Title translation How does ribavirin improve interferon α a response rates in hepatitis C virus infection?
    Language French
    Publishing date 2021-10-22
    Publishing country France
    Document type Journal Article
    ZDB-ID 2118387-9
    ISSN 1950-6961 ; 1267-8694
    ISSN (online) 1950-6961
    ISSN 1267-8694
    DOI 10.1684/vir.2011.2404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: La protéine non structurale NS5A du virus de l’hépatite C inhibe la sécrétion de l’apoprotéine B100.

    Chevaliez, S

    Virologie (Montrouge, France)

    2021  Volume 9, Issue 6, Page(s) 499

    Title translation Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion.
    Language French
    Publishing date 2021-10-11
    Publishing country France
    Document type Journal Article
    ZDB-ID 2118387-9
    ISSN 1950-6961 ; 1267-8694
    ISSN (online) 1950-6961
    ISSN 1267-8694
    DOI 10.1684/vir.2011.2816
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Inhibition de l’apoptose par la protéine Tax du rétrovirus oncogène HTLV1 : rôle dans le pouvoir transformant.

    Chevaliez, S

    Virologie (Montrouge, France)

    2021  Volume 10, Issue 1, Page(s) 65–66

    Title translation HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).
    Language French
    Publishing date 2021-10-11
    Publishing country France
    Document type Journal Article
    ZDB-ID 2118387-9
    ISSN 1950-6961 ; 1267-8694
    ISSN (online) 1950-6961
    ISSN 1267-8694
    DOI 10.1684/vir.2011.3469
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Mécanisme d’interférence à l’ARN vis-à-vis du virus de l’hépatite B in vivo chez la souris transgénique.

    Chevaliez, Stéphane

    Virologie (Montrouge, France)

    2021  Volume 9, Issue 1, Page(s) 70

    Title translation Clearance of hepatitis B from the liver of transgenic mice by short hairpin RNAs.
    Language French
    Publishing date 2021-08-25
    Publishing country France
    Document type Journal Article
    ZDB-ID 2118387-9
    ISSN 1950-6961 ; 1267-8694
    ISSN (online) 1950-6961
    ISSN 1267-8694
    DOI 10.1684/vir.2020.1289
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Strategies for the improvement of HCV testing and diagnosis.

    Chevaliez, Stéphane

    Expert review of anti-infective therapy

    2019  Volume 17, Issue 5, Page(s) 341–347

    Abstract: ... ...

    Abstract Introduction
    MeSH term(s) Dried Blood Spot Testing ; Hepatitis B Surface Antigens/blood ; Hepatitis C/diagnosis ; Hepatitis C/virology ; Humans ; Mass Screening/methods ; Point-of-Care Testing
    Chemical Substances Hepatitis B Surface Antigens
    Language English
    Publishing date 2019-04-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2181279-2
    ISSN 1744-8336 ; 1478-7210
    ISSN (online) 1744-8336
    ISSN 1478-7210
    DOI 10.1080/14787210.2019.1604221
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: New markers for diagnosis and management of chronic hepatitis C virus infection.

    Chevaliez, Stephane

    Annals of gastroenterology

    2014  Volume 26, Issue 2, Page(s) 98–99

    Language English
    Publishing date 2014-04-08
    Publishing country Greece
    Document type Journal Article
    ZDB-ID 2032850-3
    ISSN 1108-7471
    ISSN 1108-7471
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Dried blood spot sampling for hepatitis C virus infection: A new tool to simplify testing algorithms.

    Garrigou, Olivia / Ortonne, Valérie / Soulier, Alexandre / Chevaliez, Stéphane

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2021  Volume 141, Page(s) 104876

    MeSH term(s) Algorithms ; Dried Blood Spot Testing ; Hepacivirus/genetics ; Hepatitis C/diagnosis ; Humans
    Language English
    Publishing date 2021-06-03
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2021.104876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Is HBsAg quantification ready, for prime time?

    Chevaliez, Stéphane

    Clinics and research in hepatology and gastroenterology

    2013  Volume 37, Issue 6, Page(s) 559–563

    Abstract: Despite the availability of an efficient hepatitis B vaccine, approximately 240 million individuals are chronically infected with hepatitis B virus worldwide. One-fourth of hepatitis B surface antigen (HBsAg)-positive patients will develop complications, ...

    Abstract Despite the availability of an efficient hepatitis B vaccine, approximately 240 million individuals are chronically infected with hepatitis B virus worldwide. One-fourth of hepatitis B surface antigen (HBsAg)-positive patients will develop complications, such as cirrhosis or hepatocellular carcinoma, both major causes of liver-related deaths. Antiviral therapies, such as pegylated interferon alpha or nucleoside/nucleotide analogues, are effective in suppressing HBV DNA and reducing the subsequent risk of fibrosis progression, cirrhosis and hepatocellular carcinoma. HBsAg has proven to be a steady, reliable marker of chronic HBV carriage that can also be used to predict clinical outcomes. Three commercial enzyme immunoassays are now available for HBsAg quantification. A number of recent studies have shown clinical utility of HBsAg quantification in combination with HBV DNA levels to identify inactive carriers who need antiviral therapy and in interferon treated-patients in order to predict the virological response to pegylated interferon alpha.
    MeSH term(s) Antiviral Agents/therapeutic use ; Biomarkers/blood ; DNA, Viral/blood ; HIV Infections/complications ; Hepatitis B Surface Antigens/blood ; Hepatitis B virus/genetics ; Hepatitis B virus/immunology ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/diagnosis ; Hepatitis B, Chronic/drug therapy ; Hepatitis D, Chronic/complications ; Humans ; Interferon-alpha/therapeutic use ; Nucleosides/therapeutic use ; Nucleotides/therapeutic use ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use
    Chemical Substances Antiviral Agents ; Biomarkers ; DNA, Viral ; Hepatitis B Surface Antigens ; Interferon-alpha ; Nucleosides ; Nucleotides ; Recombinant Proteins ; Polyethylene Glycols (30IQX730WE) ; peginterferon alfa-2b (G8RGG88B68) ; peginterferon alfa-2a (Q46947FE7K)
    Language English
    Publishing date 2013-12
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2594333-9
    ISSN 2210-741X ; 2210-7401
    ISSN (online) 2210-741X
    ISSN 2210-7401
    DOI 10.1016/j.clinre.2013.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Virological tools to diagnose and monitor hepatitis C virus infection.

    Chevaliez, S

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2011  Volume 17, Issue 2, Page(s) 116–121

    Abstract: Approximately 200 million people are chronically infected with hepatitis C virus (HCV). Infection with HCV is curable by therapy, with the current standard treatment based on the combination of pegylated interferon-α and ribavirin. Viral eradication is ... ...

    Abstract Approximately 200 million people are chronically infected with hepatitis C virus (HCV). Infection with HCV is curable by therapy, with the current standard treatment based on the combination of pegylated interferon-α and ribavirin. Viral eradication is achieved in approximately half of treated patients. In 2011 a new antiviral treatment based on a triple combination with a protease inhibitor will become available. Virological tools are essential to diagnose HCV infection but they have found their principal application in guiding treatment decisions and assessing the virological responses to therapy. These include the anti-HCV antibody assay, measurements of HCV core antigen and HCV viral load and HCV genotyping. The HCV RNA can be ideally assayed by a real-time assay with a limit of detection of 10-15 IU/mL. Monitoring of viral kinetics during the early phases of antiviral treatment is crucial in making treatment decisions such as early stopping rules and also in optimizing the treatment duration. The HCV genotype should be assessed before the start of treatment because it determines the treatment length and ribavirin dose and also offers prognostic information on treatment outcomes as certain genotypes respond more favourably to treatment.
    MeSH term(s) Antiviral Agents/therapeutic use ; Clinical Laboratory Techniques/methods ; Drug Monitoring/methods ; Hepacivirus/isolation & purification ; Hepatitis C/diagnosis ; Hepatitis C/drug therapy ; Hepatitis C/virology ; Hepatitis C Antibodies/blood ; Hepatitis C Antigens/blood ; Humans ; Immunoassay/methods ; RNA, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Viral Load/methods ; Virology/methods
    Chemical Substances Antiviral Agents ; Hepatitis C Antibodies ; Hepatitis C Antigens ; RNA, Viral
    Language English
    Publishing date 2011-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1111/j.1469-0691.2010.03418.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top